Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04852601 · ClinicalTrials.gov registry record · NA
ToolBox Detect: Low Cost Detection of Cognitive Decline in Primary Care Settings
A NA study of Dementia and Cognitive Dysfunction, sponsored by Northwestern University.
- Active
- Registry status
- NA
- Development phase
- 41,500
- Enrollment target
- 1
- Study location
NCT04852601: Active NA study of Dementia and Cognitive Dysfunction, sponsored by Northwestern University.
NCT04852601 is a NA study of Dementia and Cognitive Dysfunction that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 41,500 participants, above the 7,514-participant average among 199 other Dementia trials with a reported enrollment target (452% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04852601, a NA study of Dementia and Cognitive Dysfunction, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 41,500 participants
- Enrollment target
- 1
- Study location
Study Summary
Our study objective is to widely implement and evaluate a user-centered, scalable, electronic health record (EHR)-linked strategy for the routine detection of cognitive decline among diverse primary care settings. This strategy, called ToolboxDetect, will provide an efficient and sensitive cognitive screen that can be easily implemented in everyday clinical settings, and is responsive to patient, family, and caregiver concerns for potential symptoms of cognitive decline (CD) and cognitive impairment (CI).
Primary Outcome
This will be operationalized as either results of an any administered cognitive test suggesting impairment ('detected'), or having any relevant ICD 10 classification code recorded in a patient's record after the trial launch date and throughout follow-up observation period ('diagnosis').
Conditions Studied
Interventions
- OTHER ToolboxDetect
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41,500 participants |
| Start Date | 2022-08-25 |
| Est. Completion | 2026-05 |
| Phase | NA |
What the registry record for NCT04852601 still lists
NCT04852601 is an interventional study that assigns participants to a tested intervention. Its 41,500 participants enrollment target places it among the larger protocols in the corpus, above the 7,514-participant average among 199 other Dementia trials with a reported enrollment target (452% higher).
The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which ToolboxDetect is the first listed.
NCT04852601 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04852601 about?
NCT04852601 is a clinical study titled "ToolBox Detect: Low Cost Detection of Cognitive Decline in Primary Care Settings". Our study objective is to widely implement and evaluate a user-centered, scalable, electronic health record (EHR)-linked strategy for the routine detection of cognitive decline among diverse primary care settings. This strategy, called ToolboxDetect, will provide an efficient and sensitive cognitive...
What is the current status of trial NCT04852601?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 41,500 participants. The study started on 2022-08-25. Estimated completion is 2026-05.
What conditions does trial NCT04852601 study?
This clinical trial studies the following conditions: Dementia, Cognitive Dysfunction.
What interventions are being tested in trial NCT04852601?
The interventions under investigation include: ToolboxDetect (OTHER).
Who is sponsoring clinical trial NCT04852601?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04852601 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04852601's enrollment target sits among peer trials
41,500 7th of 199 higher than 193 of 199 other Dementia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Caregiver Bootcamp
RECRUITING · NA
-
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
RECRUITING · NA
-
Effect of Cognitive Empathy Training on Dementia Caregivers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01255748 · 40,000 participants
Registry Study for Radiation Therapy Outcomes
- NCT04994756 · 40,000 participants
Stroke Thrombectomy and Aneurysm Registry
- NCT06768814 · 40,000 participants · NA
Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
- NCT07109427 · 40,000 participants · NA
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI